A robot cheetah now runs 45 km/h, faster than Usain Bolt's top speed.
It's not the strangest one.
A robot spider skeleton comes off a 3D printer. 26 servo motors. $1,385 with skin, $250 without.
A robot manta ray took 2 years and 40 fin designs before Singapore researchers landed on flexible PVC pectoral fins. It swims at twice its body length per second. 10 hours underwater before it needs to surface.
A robot dragonfly from Germany weighs 175 grams. 27-inch wingspan. Flies forward, backward, sideways, hovers, just like the real thing.
Boston Dynamics built a dog that carries 500 kg and hits 25 km/h. It can open doors on its own.
A 6-legged crab robot drops 200 meters underwater on 30 joints and grips objects with its front claws.
A robotic kangaroo weighs 7 kg and jumps 80 cm, recycling the energy from each landing into the next leap.
An AI puppy remembers what earns praise and repeats it. Eyes are screens. $2,899.
None of these were built to look pretty.
They were built because evolution already solved the problem first.
显示更多
Joe Rogan yells "Holy sh*t!" after Harvard professor of genetics David Sinclair says sudden blindness has DOUBLED because of GLP-1 drugs.
Then Rogan pulls up the data himself — and what he reads out loud is even worse.
SINCLAIR: "Glaucoma and also sudden blindness. It's called NAION, which is now twice as more prevalent because of the GLP-1 drugs."
ROGAN: "Really?!"
SINCLAIR: "It's not well known. Obviously companies don't want to talk about it. But yes, sudden blindness has doubled, seemingly because of these meds."
ROGAN: "Holy shit!"
SINCLAIR: "Careful."
ROGAN: "Sudden blindness has doubled because of GLP-1s?"
SINCLAIR: "Due to NAION, which is like a stroke in your eye, and then your other eye can go. Which is pretty scary. And there's nothing you can do about it. Hopefully our drug does work for those people."
ROGAN: "And, obviously correlation does not equal causation, but it seems to be."
SINCLAIR: "Yeah, there's a scientist at Harvard. You could look up his work. Joe Rizzo. It looks like it's repeatable across the planet."
ROGAN: "Wow, that's terrible. Terrible because there's so many people out there that are just telling everyone they should get on GLP-1s… Like online podcasters saying, 'Everyone should get on GLP-1s… It's going to transform society.' I'm like, 'We just started taking these! The f*ck are you saying?!'"
SINCLAIR: "Yeah, it's not risk free. Same with ED drugs."
ROGAN: "Here goes. Recent studies suggest that a potential risk — rare link between GLP-1 receptor agonist medications such as Ozempic, Wegovy, blah, blah, blah, and… an eye stroke [that] can cause sudden, painless loss of vision in one eye, while absolute risk remains very low."
ROGAN: "Well, very low is like… What does that mean?"
SINCLAIR: "One in 10,000 people."
ROGAN: "One in 10,000?"
SINCLAIR: "Oh no. Total of 10,000."
ROGAN: "Oh, total of 10,000 so far? How many people are taking this stuff?"
[Rogan continues reading]
"The drugs were 68.6 times more likely to develop this [eye stroke] and 8 times more likely to develop… diabetic retinopathy."
ROGAN: "Oh, my God. Then… Wow."
ROGAN: "Yeah, man. These things are just — they're just rolling out…"
显示更多